Report Store

France Pricing and Reimbursement: If you can make it there, you can make it anywhere

€1.200,00

France is considered one of the most challenging markets for HTA appraisal. However, products which convince the authorities are reimbursed at attractive prices and the reimbursed early access program ATU is one of the best if not the best in the world.

SKU: France Pricing and Reimbursement Categories: , , , Tags: ,

Description

This section will provide an overview and understanding of:

  • Key stakeholders in the French retail & hospital market
  • Pricing and Reimbursement timelines in France
  • Key determinants, such as the SMR and ASMR, influencing the reimbursement status and pricing potential of an asset
  • Recent trends within SMR and ASMR assessments
  • Extra funding pathways for hospital products
  • Opportunities for early access and reimbursement in France via the ATU program
  • Analogue examples of drugs with ATU pathway
  • Illustrative analogue cases showcasing assessment and pricing trends for specific therapeutic areas

Related products

2